(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.08%) $0.926
(-0.15%) $10.82
(-0.09%) $0.792
(-0.09%) $92.49
@ $0.897
Issued: 14 Feb 2024 @ 15:28
Return: -11.86%
Previous signal: Feb 14 - 10:42
Previous signal:
Return: -0.39 %
Live Chart Being Loaded With Signals
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States...
Stats | |
---|---|
Today's Volume | 122 822 |
Average Volume | 1.53M |
Market Cap | 2.49M |
EPS | $0 ( 2024-03-19 ) |
Next earnings date | ( $-0.860 ) 2024-04-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.170 |
ATR14 | $0.0150 (1.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-02 | Gower Bob G | Buy | 90 287 | Common Stock |
2023-03-01 | Gower Bob G | Buy | 270 000 | Common Stock |
2023-02-28 | Gower Bob G | Buy | 109 300 | Common Stock |
2022-12-09 | Gower Bob G | Buy | 357 143 | Common Stock |
2022-12-09 | Gower Bob G | Buy | 714 286 | Warrants |
INSIDER POWER |
---|
96.87 |
Last 80 transactions |
Buy: 23 095 136 | Sell: 3 675 006 |
Volume Correlation
Ensysce Biosciences, Inc. Correlation
10 Most Positive Correlations | |
---|---|
SVAC | 0.928 |
PAIC | 0.905 |
PRVB | 0.904 |
SVOK | 0.878 |
ALR | 0.862 |
TLGT | 0.852 |
ALLR | 0.847 |
LKCO | 0.844 |
RDHL | 0.843 |
ELEV | 0.839 |
10 Most Negative Correlations | |
---|---|
NETE | -0.92 |
LWAC | -0.92 |
MDRRP | -0.916 |
SRAC | -0.904 |
WSBCP | -0.895 |
RAVN | -0.889 |
HNST | -0.889 |
OVBC | -0.886 |
MRBK | -0.885 |
MNSBP | -0.883 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ensysce Biosciences, Inc. Correlation - Currency/Commodity
Ensysce Biosciences, Inc. Financials
Annual | 2023 |
Revenue: | $2.23M |
Gross Profit: | $2.23M (100.00 %) |
EPS: | $-4.69 |
Q4 | 2023 |
Revenue: | $515 032 |
Gross Profit: | $-2.92M (-567.87 %) |
EPS: | $-1.550 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.870 |
Q2 | 2023 |
Revenue: | $490 472 |
Gross Profit: | $-1.15M (-235.13 %) |
EPS: | $-0.980 |
Financial Reports:
No articles found.
Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators